// App-Quantinova.ai

3016 : KPT-9274 inhibits cellular NAD and synergizes with NAD depleting enzymes to induce cancer cell death

Researchers

Presenter

  • Christian Argueta

Principal Investigators

  • Trinayan Kashyap

  • Margaret Lee

  • Yosef Landesman

  • Sharon Shacham

  • William Senapedis

  • Erkan Baloglu

Medical Centers

  • Karyopharm Therapeutics, Newton, MA

Locations

  • United States

Companies

  • Karyopharm Therapeut

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved